Articles related to ARTIFICIAL INTELLIGENCE (AI)

AI chatbots like ChatGPT-4 and Claude AI have demonstrated superior performance to oncologists in delivering accurate, empathetic, and readable responses to patient inquiries about cancer, suggesting a promising adjunct to clinical practice.

A study presented at AAPA 2024 shows that AI, particularly a multilayer perceptron model, significantly improves the prediction of in-hospital cardiac arrest in emergency settings compared to the traditional Modified Early Warning Score.

An innovative blood test using artificial intelligence has shown the potential to detect Parkinson’s disease up to seven years before symptoms appear, offering new possibilities for early intervention and treatment.

Tempus AI, leveraging one of the world’s largest clinical and molecular oncology data libraries, files for an IPO, aiming to raise substantial funds to support its mission of advancing AI-powered precision medicine.

The 2024 ASCO Annual Meeting reveals critical updates on lung and blood cancers, including promising phase 3 trial results and the innovative use of AI to reengage marginalized patients in cancer care.

GPT-4 demonstrates impressive capabilities in medical applications, from note-taking to consultation. However, its use requires careful prompt engineering and continuous error monitoring to ensure safe and effective integration into clinical practice.